XLV:NYE-Health Care Select Sector SPDR® Fund (USD)

ETF | Health |

Last Closing

USD 153.13

Change

0.00 (0.00)%

Market Cap

USD 41.35B

Volume

9.82M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

ETFs Containing XLV

HYLG Global X Funds - Global X.. 53.23 % 0.00 %

N/A

N/A
THLV THOR Financial Technologi.. 13.95 % 0.00 %

N/A

USD 0.05B
TACK Fairlead Tactical Sector .. 12.07 % 0.00 %

N/A

USD 0.22B
AESR 9.87 % 0.00 %

N/A

N/A
PSTR PeakShares Sector Rotatio.. 9.64 % 0.00 %

N/A

USD 4.85M
HAC:CA Global X Seasonal Rotatio.. 4.39 % 1.27 %

N/A

CAD 0.22B
EQL ALPS Equal Sector Weight .. 0.00 % 0.15 %

N/A

N/A
FUT:CA 0.00 % 0.81 %

N/A

N/A
QGTA 0.00 % 0.37 %

N/A

N/A
QLS 0.00 % 0.76 %

N/A

N/A
EQL ALPS Equal Sector Weight .. 0.00 % 0.26 %

N/A

N/A
EQL ALPS Equal Sector Weight .. 0.00 % 0.26 %

N/A

N/A
XLSR SPDR® SSGA U.S. Sector R.. 0.00 % 0.00 %

N/A

USD 0.62B
USHG 0.00 % 0.00 %

N/A

N/A
LCR Leuthold Core ETF 0.00 % 0.00 %

N/A

USD 0.09B
SSUS Day Hagan/Ned Davis Resea.. 0.00 % 0.00 %

N/A

USD 0.61B
QPX AdvisorShares Q Dynamic G.. 0.00 % 0.00 %

N/A

USD 0.03B
TDSB Cabana Target Drawdown 7 .. 0.00 % 0.00 %

N/A

USD 0.09B
TDSC Cabana Target Drawdown 10.. 0.00 % 0.00 %

N/A

USD 0.21B
FATT 0.00 % 0.00 %

N/A

N/A
CLSM Cabana Target Leading Sec.. 0.00 % 0.00 %

N/A

USD 0.16B
RSPY 0.00 % 0.00 %

N/A

N/A
RRH 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.28% 86% B+ 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.28% 86% B+ 63% D
Trailing 12 Months  
Capital Gain 19.58% 52% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.58% 52% F 54% F
Trailing 5 Years  
Capital Gain 66.70% 95% A 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.70% 95% A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.75% 100% F 67% D+
Dividend Return 10.87% 100% F 63% D
Total Return 1.12% 89% A- 25% F
Risk Return Profile  
Volatility (Standard Deviation) 10.62% 100% F 77% C+
Risk Adjusted Return 102.35% 100% F 97% N/A
Market Capitalization 41.35B 100% F 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike